Vision problems sometimes go beyond what can be corrected with a stronger prescription for glasses ... glaucoma or diabetic retinopathy. These conditions become more common with age and can ...

Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a major public health concern in India.

Advances in diagnostic technologies have made it possible to detect diseases such as glaucoma and diabetic ... AR glasses can overlay critical information during complex procedures, enhancing ...

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) With as few as two treatments per year, Susvimo ...

Vision problems sometimes go beyond what can be corrected with a stronger prescription for glasses ... degeneration (AMD), glaucoma, or diabetic retinopathy. These conditions become more common ...

Soliddd’s scientifically formulated and user-tested virtual reality smartglasses ... age-related macular degeneration, glaucoma, diabetic retinopathy and stroke,” said Georgia Crozier ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4 ...

The primary care optometrists and hospital consultants agreed on diabetic retinopathy status in patients, researchers found. The primary care service catered to patients unsuitable for virtual ...

Diabetic retinopathy is an eye condition that occurs when high blood sugar levels damage the blood vessels in your retina—the light-sensitive tissue at the back of your eye that helps you to see ...

APX3330 is an oral, small-molecule Ref-1 inhibitor being developed for treating diabetic ... retinopathy in the phase 2 ZETA-1 trial. Ocuphire Pharma’s study results were presented at the ...